Theravance (TBPH) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $17.00 from $15.00 | Jul 7, 2026 |
| Jones Trading | Downgraded | Buy → Hold | — | Jun 29, 2026 |
| BTIG | Downgraded | Buy → Neutral | — | Jun 29, 2026 |
| B. Riley Securities | Maintained | Neutral | $17.00 from $14.00 | Apr 7, 2026 |
| TD Cowen | Maintained | Hold | $15.00 from $13.00 | Mar 23, 2026 |
| BTIG | Maintained | Buy | $21.00 | Mar 20, 2026 |
| Oppenheimer | Downgraded | Outperform → Perform | — | Mar 5, 2026 |
| B. Riley Securities | Downgraded | Buy → Neutral | $14.00 from $28.00 | Mar 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 from $27.00 | Mar 4, 2026 |
| BTIG | Maintained | Buy | $21.00 from $40.00 | Mar 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $27.00 from $20.00 | Mar 2, 2026 |
| BTIG | Maintained | Buy | $40.00 | Feb 3, 2026 |
| Oppenheimer | Initiated Coverage | Outperform | $27.00 | Dec 3, 2025 |
| BTIG | Maintained | Buy | $40.00 from $25.00 | Nov 26, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $15.00 | Nov 11, 2025 |
| B. Riley Securities | Initiated Coverage | Buy | $28.00 | Sep 12, 2025 |
| BTIG | Maintained | Buy | $25.00 from $24.00 | Jun 27, 2025 |
| Jones Trading | Initiated Coverage | Buy | $24.00 | Jun 17, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Feb 27, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Feb 25, 2025 |
Frequently asked questions
Is TBPH a buy, sell, or hold?
Analysts covering Theravance currently average a Hold rating: 0 buy, 4 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on TBPH?
On Jul 7, 2026, HC Wainwright & Co. downgraded Theravance to Neutral with a price target of $17.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.